CFHR1 and age-related macular degeneration: Consistently, structural variants (SVs) resulting in deletions of CFHR1 and CFHR316 or of CFHR1 and CFHR420, respectively, have been proposed to reduce AMD risk, although the independence of such effects from CFH has remained contested21,22.